Plant ID: NPO7213
Plant Latin Name: Toddalia asiatica
Taxonomy Genus: Toddalia
Taxonomy Family: Rutaceae
NCBI TaxonomyDB:
159068
Plant-of-the-World-Online:
775412-1
Madagascar; Bangladesh; Sudan; Vietnam; Philippines; Nepal; India; Zimbabwe; Zambia; Mauritius; Ethiopia; Rwanda; China; Mozambique; Swaziland; Thailand; Burundi; Kenya; Tanzania; Malawi; Uganda
TSHR; | |
PDE4D; | |
MTOR; ALOX15; ALDH1A1; | |
TP53; | |
LMNA; THPO; | |
SMN1;SMN2; |
Protein Class | Gene ID | Protein Name | Uniprot ID | Target ChEMBL ID |
---|---|---|---|---|
Cytochrome P450 family 1 | CYP1A2 | Cytochrome P450 1A2 | P05177 | CHEMBL3356 |
Cytochrome P450 family 2 | CYP2D6 | Cytochrome P450 2D6 | P10635 | CHEMBL289 |
Cytochrome P450 family 2 | CYP2C19 | Cytochrome P450 2C19 | P33261 | CHEMBL3622 |
Cytochrome P450 family 2 | CYP2C9 | Cytochrome P450 2C9 | P11712 | CHEMBL3397 |
Cytochrome P450 family 3 | CYP3A4 | Cytochrome P450 3A4 | P08684 | CHEMBL340 |
Enzyme_unclassified | MTOR | Serine/threonine-protein kinase mTOR | P42345 | CHEMBL2842 |
Enzyme_unclassified | ALOX15 | Arachidonate 15-lipoxygenase | P16050 | CHEMBL2903 |
Enzyme_unclassified | ALDH1A1 | Aldehyde dehydrogenase 1A1 | P00352 | CHEMBL3577 |
Methyl-lysine/arginine binding protein | SMN1;SMN2 | Survival motor neuron protein | Q16637 | CHEMBL1293232 |
Peptide receptor (family A GPCR) | TSHR | Thyroid stimulating hormone receptor | P16473 | CHEMBL1963 |
Phosphodiesterase 4 | PDE4D | Phosphodiesterase 4D | Q08499 | CHEMBL288 |
Transcription Factor | TP53 | Cellular tumor antigen p53 | P04637 | CHEMBL4096 |
Unclassified | LMNA | Prelamin-A/C | P02545 | CHEMBL1293235 |
Unclassified | THPO | Thrombopoietin | P40225 | CHEMBL1293256 |
GO Type | GO Category | Enriched GO Terms | p-Value | Adjusted p-Value | Enriched Genes |
---|---|---|---|---|---|
BP | GO:0050896; response to stimulus | GO:0042738; exogenous drug catabolic process | 1.161E-10 | 6.560E-07 | CYP1A2, CYP2C19, CYP2C9, CYP3A4 |
BP | GO:0008152; metabolic process | GO:0070989; oxidative demethylation | 1.161E-10 | 6.560E-07 | CYP1A2, CYP2C9, CYP2D6, CYP3A4 |
MF | GO:0005488; binding | GO:0019825; oxygen binding | 1.610E-10 | 7.012E-07 | CYP1A2, CYP2C19, CYP2C9, CYP2D6, CYP3A4 |
MF | GO:0005488; binding | GO:0005506; iron ion binding | 1.383E-09 | 3.298E-06 | ALOX15, CYP1A2, CYP2C19, CYP2C9, CYP2D6, CYP3A4 |
MF | GO:0003824; catalytic activity | GO:0034875; caffeine oxidase activity | 1.515E-09 | 3.298E-06 | CYP1A2, CYP2C9, CYP3A4 |
MF | GO:0003824; catalytic activity | GO:0008395; steroid hydroxylase activity | 1.077E-08 | 1.675E-05 | CYP2C19, CYP2C9, CYP2D6, CYP3A4 |
BP | GO:0008152; metabolic process | GO:0006805; xenobiotic metabolic process | 1.878E-08 | 2.272E-05 | CYP1A2, CYP2C19, CYP2C9, CYP2D6, CYP3A4 |
MF | GO:0005488; binding | GO:0020037; heme binding | 3.364E-08 | 3.662E-05 | CYP1A2, CYP2C19, CYP2C9, CYP2D6, CYP3A4 |
BP | GO:0008152; metabolic process | GO:0097267; omega-hydroxylase P450 pathway | 4.532E-08 | 4.699E-05 | CYP1A2, CYP2C19, CYP2C9 |
BP | GO:0008152; metabolic process | GO:0019373; epoxygenase P450 pathway | 4.997E-07 | 4.030E-04 | CYP1A2, CYP2C19, CYP2C9 |
MF | GO:0003824; catalytic activity | GO:0070330; aromatase activity | 6.647E-07 | 4.991E-04 | CYP1A2, CYP2D6, CYP3A4 |
BP | GO:0008152; metabolic process | GO:0008202; steroid metabolic process | 8.881E-07 | 6.446E-04 | CYP1A2, CYP2C19, CYP2C9, CYP2D6, CYP3A4 |
BP | GO:0008152; metabolic process | GO:0044281; small molecule metabolic process | 1.046E-06 | 6.899E-04 | ALDH1A1, ALOX15, CYP1A2, CYP2C19, CYP2C9, CYP2D6, CYP3A4, MTOR, PDE4D |
BP | GO:0008152; metabolic process | GO:0009822; alkaloid catabolic process | 1.688E-06 | 1.050E-03 | CYP2D6, CYP3A4 |
BP | GO:0008152; metabolic process | GO:0016098; monoterpenoid metabolic process | 8.042E-16 | 1.751E-11 | CYP1A2, CYP2C19, CYP2C9, CYP2D6, CYP3A4 |
CC | GO:0043226; organelle | GO:0097504; Gemini of coiled bodies | 3.698E-05 | 1.751E-02 | SMN1, SMN2 |
CC | GO:0016020; membrane | GO:0005789; endoplasmic reticulum membrane | 3.992E-05 | 1.850E-02 | CYP1A2, CYP2C19, CYP2C9, CYP2D6, CYP3A4, MTOR |
CC | GO:0032991; macromolecular complex | GO:0032797; SMN complex | 4.369E-05 | 1.982E-02 | SMN1, SMN2 |
CC | GO:0044464; cell part | GO:0034719; SMN-Sm protein complex | 8.550E-05 | 3.325E-02 | SMN1, SMN2 |
Pathway Category Top Level | Pathway Category Second Level | Pathway ID | Pathway Name | p-Value | Adjusted p-Value | Enriched Genes |
---|---|---|---|---|---|---|
09100 Metabolism | 09103 Lipid metabolism | hsa00591 | Linoleic acid metabolism | 1.325E-11 | 9.935E-10 | CYP2C9, CYP1A2, ALOX15, CYP3A4, CYP2C19 |
09100 Metabolism | 09111 Xenobiotics biodegradation and metabolism | hsa00982 | Drug metabolism - cytochrome P450 | 1.233E-09 | 4.623E-08 | CYP2C9, CYP2D6, CYP1A2, CYP3A4, CYP2C19 |
09100 Metabolism | 09108 Metabolism of cofactors and vitamins | hsa00830 | Retinol metabolism | 1.350E-07 | 3.375E-06 | CYP2C9, CYP1A2, ALDH1A1, CYP3A4 |
09100 Metabolism | 09111 Xenobiotics biodegradation and metabolism | hsa00980 | Metabolism of xenobiotics by cytochrome P450 | 2.162E-07 | 4.055E-06 | CYP2C9, CYP2D6, CYP1A2, CYP3A4 |
09150 Organismal Systems | 09156 Nervous system | hsa04726 | Serotonergic synapse | 1.213E-06 | 1.516E-05 | CYP2C9, CYP2D6, ALOX15, CYP2C19 |
09160 Human Diseases | 09161 Cancers | hsa05204 | Chemical carcinogenesis | 3.461E-07 | 5.192E-06 | CYP2C9, CYP1A2, CYP3A4, CYP2C19 |
09100 Metabolism | 09103 Lipid metabolism | hsa00590 | Arachidonic acid metabolism | 1.257E-05 | 1.347E-04 | CYP2C9, ALOX15, CYP2C19 |
Unclassified | Unclassified | hsa01100 | Metabolic pathways | 1.720E-04 | 1.612E-03 | CYP2C9, CYP1A2, ALOX15, ALDH1A1, CYP2C19, CYP3A4 |
09160 Human Diseases | 09161 Cancers | hsa05214 | Glioma | 1.063E-03 | 7.695E-03 | TP53, MTOR |
09160 Human Diseases | 09161 Cancers | hsa05230 | Central carbon metabolism in cancer | 1.129E-03 | 7.695E-03 | TP53, MTOR |
09100 Metabolism | 09103 Lipid metabolism | hsa00140 | Steroid hormone biosynthesis | 8.471E-04 | 7.059E-03 | CYP1A2, CYP3A4 |
ICD10 Disease Category | Disease Name | ICD10 Code | Associated Disease Targets (Association Ref: TTD database) |
---|---|---|---|
J00-J99: Diseases of the respiratory system | Bronchitis | J20-J21, J42 | PDE4D; |
G00-G99: Diseases of the nervous system G00-G99 | Migraine | G43 | CYP2D6; |
A00-B99: Certain infectious and parasitic diseases | Malaria | B54 | CYP2D6; |
L00-L99: Diseases of the skin and subcutaneous tissue | Psoriasis | L40 | PDE4D; |
F01-F99: Mental, Behavioral and Neurodevelopmental disorders | Insomnia | F51.0, G47.0 | CYP2D6; |
L00-L99: Diseases of the skin and subcutaneous tissue | Atopic dermatitis | L00-L99 | PDE4D; |
J00-J99: Diseases of the respiratory system | Asthma | J45 | PDE4D; |
J00-J99: Diseases of the respiratory system | Emphysema | J43 | PDE4D; |
J00-J99: Diseases of the respiratory system | Chronic obstructive pulmonary disease | J40-J44, J47 | PDE4D; |